Thus , in addition to the eight patients who were randomly assigned to receive bevacizumab plus lomustine 110 mg/m ( 2 ) , 51 patients were assigned to receive bevacizumab alone , 47 to receive lomustine alone , and 47 to receive bevacizumab plus lomustine 90 mg/m ( 2 ) .